Development of biodegradable polymeric paste formulations for taxol: An in vitro and in vivo study

International Journal of Pharmaceutics

Volumn 137, Issue 2, 1996, Pages 199-208

  Zhang, Xichen ^a,c   Jackson, John K ^a   Wong, Wesley ^a   Min, Weixian ^b   Cruz, Tony ^b   Hunter, William L ^c   Burt, Helen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Angiogenesis Technologies Inc   (Canada)

Author keywords

Biodegradable polymers; In vitro release; Paste; Taxol; Tumor inhibition

Indexed keywords

COPOLYMER; PACLITAXEL; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH;

EID: 0030604694     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04521-8     Document Type: Article

References (23)

1. Cohn, D. and Younes, H., Biodegradable PEO/PLA block copolymers. J. Biomed. Mater. Res., 22 (1988) 993-1009.
2. Deng, X.M., Xiong, C.D., Cheng, L.M, and Xu, R.P., Synthesis and characterization of block copolymers from D,L-lactide and poly(ethylene glycol) with stannous chloride. J. Polym. Sci. Polym. Lett., 28 (1990) 411-416.
3. Fukuzaki, H., Yoshida, M., Asano, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K., Yamanaka, H., Kawaharada, U. and Suzuki, K., A new biodegradable copolymer of glycolic acid and lactones with relatively low molecular weight prepared by direct copolycondensation in the absence of catalysts. J. Biomed. Mater. Res., 25 (1991) 315-328.
4. 14C-fluorouracil in murine fibrosarcomas. Pharm. Res., 12 (1995a) S227.
5. 195Pt-cisplatin in murine tumors with a novel injectable sustained-release drug-delivery system. Pharm. Res., 12 (1995b) S228.
6. Kubo, O., Tajika, Y., Muragaki, Y., Hiyama, H., Takakura, K., Yoshida, M. and Kumakura, M., Local chemotherapy with slowly-releasing anti-cancer drug-polymers for malignant brain tumors. J. Controlled Rel., 32 (1994) 1-8.
7. Li, Y., Volland, C. and Kissel, T., In vitro degradation and bovine serum albumin release of the ABA triblock copolymers consisting of poly(L( + ) lactic acid), or poly(L( + ) lactic acid-co-glycolic acid) A blocks attached to central polyoxyethylene B blocks. J. Controlled Rel., 32 (1994) 121-128.
8. Li, Y. and Kissel, T., Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks. J. Controlled Rel., 27 (1993) 247-257.
9. Li, S.M., Garreau, H. and Vert, M., Structure-property relationships in the case of the degradation of solid aliphatic poly(α-hydroxy acids) in aqueous media, I: poly(D,L-lactic acid). J. Mater. Sci. Mater. Med., 1 (1990) 123-130.
10. Maulding, H.V., Prolonged delivery of peptides by microcapsules. J. Controlled Rel., 6 (1987) 167-176.
11. Onetto, N., Canett, R., Winograd, B., Catane, R., Dougan, M., Grechko, J., Burroughs, J. and Rozencweig, M., Overview of taxol safety. J. Natl. Cancer Inst. Monographs, 15 (1993) 131-139.
12. Pitt, C.G., Gratzl, M.M., Kimmel, G.L., Surles, J. and Schindler, A., Aliphatic polyesters II. the degradation of poly(D,L-lactide), poly(ε-caprolactone) and their copolymers in vivo. Biomater., 2 (1981) 215-220.
13. Rooney, P., Kumar, S., Ponting, J. and Wang, P., The role of hyaluronan in tumor neovascularization (Review). Int. J. Cancer, 60 (1995) 632-636.
14. Sato, S., Baba, Y., Tajima, K., Kimura, T., Tsuji, M.H., Kohda, Y. and Sato, Y., Prolongation of epidural anesthesia in the rabbit with the use of a biodegradable copolymer paste containing lidocaine. Anesth. Analg., 80 (1995) 97-101.
15. Sawhney, A.S. and Hubbell, J.A., Rapidly degraded terpolymers of D,L-lactide, glycolide, and ε-caprolactone with increased hydrophilicity by copolymerization with polyethers. J. Biomed. Mater. Res., 24 (1990) 1397-1411.
16. Siegal, R.A., Modeling of drug release from porous polymers. In Rosoff, M. (Ed.), Controlled Release of Drugs, Polymer and Aggregate System. VCH Publishers, New York, 1990, pp. 1-51.
17. Spencer, C.M. and Faulds, D., Paclitaxel: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs, 48 (1994) 794-847.
18. Stearns, M.E, and Wang, M., Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer Res., 52 (1992) 3766-3781.
19. Walter, K.A., Cahan, M.A., Gur, A., Tyler, B., Hilton, J., Colvin, O.M., Burger, P.C., Domb, A. and Brem, H., Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Can. Res., 54 (1994) 2207-2212.
20. Winternitz, C.I., Jackson, J.K., Oktaba, A.M. and Burt, H.M., Development of a polymeric surgical paste formulation of taxol. Pharm. Res., 13 (1996) 368-375.
21. Wu, M.P., Tamada, J.A., Brem, H. and Langer, R., In vivo vesus in vitro degradation of controlled release polymers for intracranial surgical therapy. J. Biomed. Mater. Res., 28 (1994) 387-395.
22. Zhang, X., Wyss, U.P., Pichora, D. and Goosen, M.F.A., Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J. Pharm. Pharmacol., 46 (1994) 718-724.
23. Zhu, K.J., Lin, X.Z. and Yang, S.L., Preparation, characterization, and properties of polylactide (PLA)-poly(ethylene glycol) (PEG) copolymers: a potential drug carrier. J. Appl. Polym. Sci., 39 (1990) 1-9.